These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 7517738)

  • 1. Tumour angiogenesis.
    Le Querrec A; Duval D; Tobelem G
    Baillieres Clin Haematol; 1993 Sep; 6(3):711-30. PubMed ID: 7517738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour angiogenesis: pathophysiology and clinical significance.
    Lichtenbeld HH; van Dam-Mieras MC; Hillen HF
    Neth J Med; 1996 Jul; 49(1):42-51. PubMed ID: 8772360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis: an update.
    Díaz-Flores L; Gutiérrez R; Varela H
    Histol Histopathol; 1994 Oct; 9(4):807-43. PubMed ID: 7534514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microenvironmental regulation of tumour angiogenesis.
    De Palma M; Biziato D; Petrova TV
    Nat Rev Cancer; 2017 Aug; 17(8):457-474. PubMed ID: 28706266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of blood cell-vessel wall interactions in tumour metastasis.
    Poggi A; Stella M; Donati MB
    Baillieres Clin Haematol; 1993 Sep; 6(3):731-52. PubMed ID: 8025349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis under normal and pathological conditions.
    Ribatti D; Vacca A; Roncali L; Dammacco F
    Haematologica; 1991; 76(4):311-20. PubMed ID: 1724438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rationale and future potential of angiogenesis inhibitors in neoplasia.
    Gasparini G
    Drugs; 1999 Jul; 58(1):17-38. PubMed ID: 10439927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumorangiogenesis: a network of cytokines.
    Hotfilder M; Nowak-Göttl U; Wolff JE
    Klin Padiatr; 1997; 209(4):265-70. PubMed ID: 9293460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas.
    Vitolo D; Ciocci L; Cicerone E; Rossi C; Tiboni F; Ferrauti P; Gallo A; Baroni CD
    J Pathol; 2001 Sep; 195(2):197-208. PubMed ID: 11592099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell growth: biology and pharmacology in relation to angiogenesis.
    Tobelem G
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):703-5. PubMed ID: 1723309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy.
    Rak JW; St Croix BD; Kerbel RS
    Anticancer Drugs; 1995 Feb; 6(1):3-18. PubMed ID: 7538829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype.
    Nguyen M; Lee MC; Wang JL; Tomlinson JS; Shao ZM; Alpaugh ML; Barsky SH
    Oncogene; 2000 Jul; 19(31):3449-59. PubMed ID: 10918603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors.
    Fernandez-Sauze S; Delfino C; Mabrouk K; Dussert C; Chinot O; Martin PM; Grisoli F; Ouafik L; Boudouresque F
    Int J Cancer; 2004 Mar; 108(6):797-804. PubMed ID: 14712479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis.
    Bahramsoltani M; Plendl J
    APMIS; 2007 Jan; 115(1):30-46. PubMed ID: 17223849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.
    McDougall SR; Anderson AR; Chaplain MA; Sherratt JA
    Bull Math Biol; 2002 Jul; 64(4):673-702. PubMed ID: 12216417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants.
    Ziche M; Donnini S; Morbidelli L; Parenti A; Gasparini G; Ledda F
    Br J Cancer; 1998 Apr; 77(7):1123-9. PubMed ID: 9569049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis and angiogenesis inhibitors in cancer.
    Giavazzi R; Taraboletti G
    Forum (Genova); 1999; 9(3):261-72. PubMed ID: 10504172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.
    Ranieri G; Patruno R; Ruggieri E; Montemurro S; Valerio P; Ribatti D
    Curr Med Chem; 2006; 13(16):1845-57. PubMed ID: 16842197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic and angiostatic factors in the molecular control of angiogenesis.
    Distler JH; Hirth A; Kurowska-Stolarska M; Gay RE; Gay S; Distler O
    Q J Nucl Med; 2003 Sep; 47(3):149-61. PubMed ID: 12897707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK; Halsør EF
    Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.